Mp72-15 determining the Marginal Benefit of Adjuvant Hormonal Therapy in Intermediate Risk Prostate Cancer Patients With Insufficient Dose Delivered by Permanent Prostate Brachytherapy

Abstract

p[0.012) and post-treatment TURP (RRR[41.63, p<0.001) increased risk of mixed incontinence. CONCLUSIONS: Overall rates of incontinence following PPB are low, whether measuring PRI or PRP. However, there is discordance between these metrics. Pre-and post-treatment TURP remain the strongest factors associated with post-procedural incontinence, though history of diabetes and EBRT are associated with increased urge incontinence, and higher NCCN risk is associated with increased stress incontinence.